Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aprea Therapeutics Inc

APRE
Current price
3.7 USD +0.06 USD (+1.65%)
Last closed 3.64 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 13 900 413 USD
Yield for 12 month +619.01 %
Week
Month
Year
APRE
21.11.2021 - 28.11.2021

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. Address: 535 Boylston St., Boston, MA, United States, 02116

Analytics

WallStreet Target Price

15 USD

P/E ratio

0.3022

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -14 448 981 USD
Operating Margin TTM -1102.72 %
PE Ratio 0.3022
Return On Assets TTM -30.41 %
PEG Ratio
Return On Equity TTM -51.87 %
Wall Street Target Price 15 USD
Revenue TTM 569 156 USD
Book Value 5.43 USD
Revenue Per Share TTM 0.17 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share 12.31 USD
Diluted Eps TTM 12.31 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics APRE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 13.02.2023
Dividend Date

Stock Valuation APRE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.3022
Forward PE
Enterprise Value Revenue
Price Sales TTM 24.4229
Enterprise Value EBITDA 1.051
Price Book MRQ 0.6704

Financials APRE

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators APRE

For 52 weeks

2.78 USD 12 USD
50 Day MA 4.17 USD
Shares Short Prior Month 115 796
200 Day MA 4.03 USD
Short Ratio 12.09
Shares Short 120 458
Short Percent 3.83 %